# ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients

> **NCT01126554** · — · COMPLETED · sponsor: **University of Zurich** · enrollment: 110 (estimated)

## Conditions studied

- Critically Ill

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01126554
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-12
- **Final completion:** 2011-02
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2014-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01126554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01126554, "ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01126554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*